• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[献血者中克氏锥虫的检测]

[Detection of Trypanosoma cruzi in blood donors].

作者信息

Novelo-Garza Bárbara Alicia, Benítez-Arvizu Gamaliel, Peña-Benítez América, Galván-Cervantes Jorge, Morales-Rojas Alejandro

机构信息

Coordinación de Planeación de Infraestructura Médica, Dirección de Prestaciones Médicas, Instituto Mexicano del Seguro Social, Distrito Federal, Mexico.

出版信息

Rev Med Inst Mex Seguro Soc. 2010 Mar-Apr;48(2):139-44.

PMID:20929616
Abstract

BACKGROUND

The American trypanosomiasis is the second parasitic disease in importance after paludism and one of the main mechanism of transmission is a blood transfusion. Our objective was to measure the effect the Tripanosoma Cruzi screening test in blood banks in the Mexican Institute of Social Security.

METHODS

Information was obtained from each unit of blood collected. The Tripanosoma cruzi prevalence was calculated only in samples with double reactivity in the blood banks.

RESULTS

Of 71 blood banks, only 26 had been doing T. Cruzi screen; after implementation of integrated services 55 are doing the screening. There were 935 donors with double reactivity to the T. Cruzi test from 230,074 samples. The national prevalence was 0.406%. The seroprevalence was 0.013% to 3.118%.

CONCLUSIONS

The screening of the T. cruzi improved the detection and increased the safety and the prevention of its transmission by blood transfusion.

摘要

背景

美洲锥虫病是仅次于疟疾的第二大重要寄生虫病,其主要传播途径之一是输血。我们的目的是评估克氏锥虫筛查试验在墨西哥社会保障局血库中的效果。

方法

收集每单位采集血液的信息。仅在血库中具有双重反应性的样本中计算克氏锥虫患病率。

结果

在71家血库中,只有26家进行克氏锥虫筛查;实施综合服务后,有55家进行筛查。在230,074份样本中,有935名献血者对克氏锥虫检测呈双重反应性。全国患病率为0.406%。血清阳性率为0.013%至3.118%。

结论

克氏锥虫筛查改善了检测效果,提高了安全性,并预防了其通过输血传播。

相似文献

1
[Detection of Trypanosoma cruzi in blood donors].[献血者中克氏锥虫的检测]
Rev Med Inst Mex Seguro Soc. 2010 Mar-Apr;48(2):139-44.
2
Prevalence of Trypanosoma cruzi infection in blood donors in El Salvador between 2001 and 2011.2001年至2011年期间萨尔瓦多献血者中克氏锥虫感染的患病率。
J Infect Dev Ctries. 2014 Aug 13;8(8):1029-36. doi: 10.3855/jidc.4035.
3
The early implementation of Trypanosoma cruzi antibody screening of donors and donations within England: preempting a problem.在英国早期实施克氏锥虫抗体筛查献血者和献血:预防问题。
Transfusion. 2012 Sep;52(9):1931-9. doi: 10.1111/j.1537-2995.2012.03599.x. Epub 2012 Mar 13.
4
Transfusion-associated Chagas disease (American trypanosomiasis) in Mexico: implications for transfusion medicine in the United States.墨西哥的输血相关恰加斯病(美洲锥虫病):对美国输血医学的启示
Transfusion. 2006 Feb;46(2):298-304. doi: 10.1111/j.1537-2995.2006.00715.x.
5
Trypanosoma cruzi: seroprevalence detected in the blood bank of the Instituto Nacional de Pediatría, Mexico City, in the period 2004 through 2009.克氏锥虫:2004 年至 2009 年期间在墨西哥城国家儿科研究所血库中检测到的血清流行率。
Transfusion. 2012 Mar;52(3):595-600. doi: 10.1111/j.1537-2995.2011.03322.x. Epub 2011 Aug 31.
6
Update on seroprevalence of anti-Trypanosoma cruzi antibodies among blood donors in northeast Mexico.墨西哥东北部献血者中抗克氏锥虫抗体血清流行率的最新情况。
Am J Trop Med Hyg. 2009 Sep;81(3):404-6.
7
Trypanosoma cruzi antibodies in blood donors in Yucatan state, Mexico.墨西哥尤卡坦州献血者中的克氏锥虫抗体
Rev Med Inst Mex Seguro Soc. 2011 Jul-Aug;49(4):367-72.
8
[Detection of antibodies against Trypanosoma cruzi in blood donors].[献血者中克氏锥虫抗体的检测]
Salud Publica Mex. 1993 Jan-Feb;35(1):56-64.
9
Cost-Effectiveness of Blood Donation Screening for Trypanosoma cruzi in Mexico.墨西哥克氏锥虫献血筛查的成本效益
PLoS Negl Trop Dis. 2016 Mar 22;10(3):e0004528. doi: 10.1371/journal.pntd.0004528. eCollection 2016 Mar.
10
Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain).西班牙加泰罗尼亚地区高危献血者中克氏锥虫感染的血清阳性率
Transfusion. 2008 Sep;48(9):1862-8. doi: 10.1111/j.1537-2995.2008.01789.x. Epub 2008 Jun 2.

引用本文的文献

1
(In)coherence between Chagas disease policy and the experiences of those affected in Mexico: The need for a transdisciplinary approach.墨西哥恰加斯病政策与患者经历之间的(不)一致性:跨学科方法的必要性。
PLoS Negl Trop Dis. 2025 May 7;19(5):e0013052. doi: 10.1371/journal.pntd.0013052. eCollection 2025 May.
2
First Report of Seropositivity to in Mexican Afro-Descendants from Guerrero and Oaxaca States.格雷罗州和瓦哈卡州墨西哥非裔后裔中[具体内容缺失]血清阳性的首次报告。
J Parasitol Res. 2024 May 8;2024:2014142. doi: 10.1155/2024/2014142. eCollection 2024.
3
Including unpublished surveys in reviews on Chagas disease in Mexico.
在关于墨西哥恰加斯病的综述中纳入未发表的调查。
Public Health Rev. 2020 Nov 11;41(1):24. doi: 10.1186/s40985-020-00140-7.
4
Estimating the current burden of Chagas disease in Mexico: A systematic review and meta-analysis of epidemiological surveys from 2006 to 2017.估算墨西哥当前的恰加斯病负担:2006 年至 2017 年流行病学调查的系统评价和荟萃分析。
PLoS Negl Trop Dis. 2019 Apr 9;13(4):e0006859. doi: 10.1371/journal.pntd.0006859. eCollection 2019 Apr.
5
Physician Knowledge, Attitudes, and Practices Related to Chagas Disease in Tabasco, Mexico.墨西哥塔巴斯科州与恰加斯病相关的医生知识、态度和实践。
Am J Trop Med Hyg. 2018 Jun;98(6):1743-1747. doi: 10.4269/ajtmh.17-0495. Epub 2018 Apr 19.
6
Cost-Effectiveness of Blood Donation Screening for Trypanosoma cruzi in Mexico.墨西哥克氏锥虫献血筛查的成本效益
PLoS Negl Trop Dis. 2016 Mar 22;10(3):e0004528. doi: 10.1371/journal.pntd.0004528. eCollection 2016 Mar.
7
Atlas of Mexican Triatominae (Reduviidae: Hemiptera) and vector transmission of Chagas disease.墨西哥锥蝽(猎蝽科:半翅目)图谱与恰加斯病的病媒传播
Mem Inst Oswaldo Cruz. 2015 May;110(3):339-52. doi: 10.1590/0074-02760140404. Epub 2015 Mar 14.
8
Opportunity cost for early treatment of Chagas disease in Mexico.墨西哥早期治疗恰加斯病的机会成本。
PLoS Negl Trop Dis. 2014 Apr 17;8(4):e2776. doi: 10.1371/journal.pntd.0002776. eCollection 2014 Apr.
9
Seroprevalence of T. cruzi infection in blood donors and Chagas cardiomyopathy in patients from the coal mining region of Coahuila, Mexico.墨西哥科阿韦拉州煤矿区献血者中克氏锥虫感染的血清流行率及患者中的恰加斯心肌病
Rev Inst Med Trop Sao Paulo. 2014 Mar-Apr;56(2):169-74. doi: 10.1590/S0036-46652014000200014.
10
Barriers to treatment access for Chagas disease in Mexico.墨西哥查加斯病治疗可及性的障碍。
PLoS Negl Trop Dis. 2013 Oct 17;7(10):e2488. doi: 10.1371/journal.pntd.0002488. eCollection 2013.